Read Full Article
Mr. Bailey currently serves as President and Chief Executive Officer and a member of the Board of Directors at AVEO Oncology. “As DPX-Survivac...
We are very pleased to welcome Michael to IMV's Board of Directors. He brings with him decades of leadership in designing corporate and commercial strategies that have produced several successful drug launches, particularly in oncology.
It is a privilege to join IMV's Board at such an exciting time for the company.